Trial Profile
An Open-label, Multiple-dose, Single-arm, Phase 1 Study to Evaluate the Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lafutidine (Primary) ; Irsogladine
- Indications Gastric ulcer; Gastritis; Peptic ulcer; Reflux oesophagitis
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 15 Jun 2016 Status changed from recruiting to completed.
- 27 Oct 2015 New trial record